Introduction. Accumulating evidence suggests that patients with abdominal aortic aneurysm (AAA) suffer from a systemic dilating condition affecting all arteries. Matrix metalloproteinases (MMPs) and their natural inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), appear to be involved in aneurysm formation, as evidenced by increased aortic tissue MMP activity and plasma MMP levels in patients with AAA. Hypothesizing that an imbalance in plasma MMP/TIMP level might be associated with a systemic dilation diathesis, we studied mechanical vessel wall properties of non-affected arteries of patients with either AAA or aorto-iliac obstructive lesions in association with plasma MMP-9 and TIMP-1 levels. Methods. Twenty-two patients with AAA and 12 with aorto-iliac occlusive disease (AOD) were included. Diastolic diameter (d) and distension (Dd) were measured at the level of the common carotid artery (CCA) and suprarenal aorta (SA) using ultrasonography. Distensibility (DC) and compliance (CC) were calculated from d, Dd and brachial pulse pressure. Plasma MMP-9 and TIMP-1 were determined with specific immunoassays. Results. The average (GSD) age was 72.3G5.6 and 65.0G8.2 years for the AAA and AOD patients, respectively, (PZ 0.005). CCA diameter was 9.1G1.3 mm in AAA patients and AOD 7.8G1.4 mm in AOD patients, PZ0.009. This difference persisted after correction for age. Plasma MMP-9 and TIMP-1 did not differ significantly between AAA and AOD patients. In the total 34 patients, the MMP-9/TIMP-1 ratio was correlated inversely with distensibility (rZK0.74, PZ 0.002) and to compliance (rZK0.58, PZ0.024) of the suprarenal aorta. Conclusions. The CCA diameter was larger in AAA patients compared to AOD patients. MMP-9/TIMP-1 ratio was associated with decreased distensibility and compliance of the suprarenal aorta. These data support the idea that AAA patients exhibit a systemic dilation diathesis, which might be attributable to MMP/TIMP imbalances.
Introduction
Abdominal aortic aneurysm (AAA) is a relatively common condition, 1 characterised by degeneration and dilational remodelling of the aortic wall. 2 Matrix metalloproteinases (MMPs) play an important role in the remodelling process by degrading extracellular matrix proteins such as elastin and collagen, 3 both of which are needed to maintain structural integrity and favourable mechanical properties. 4 In healthy tissue, MMP activity is tightly regulated by tissue inhibitors of metalloproteinases (TIMPs). 5 Imbalance of MMP/ TIMP homeostasis in aneurysmal tissue has been shown by several authors. 3, [6] [7] [8] [9] [10] Among the increasing number of MMPs that have been identified thus far, MMP-2 has most strongly been associated with small aneurysms, while MMP-9 has been linked to mediumsized, 11 large 6 or ruptured 12 aneurysms. Furthermore, plasma concentrations of MMP-9 appear not only to be associated with aneurysmal disease, 13 but also with size and expansion rate of AAAs.
14 Intriguingly, recent studies demonstrated a fall in MMP-9 plasma levels after successful exclusion of the AAA. 15, 16 The altered MMP/TIMP homeostasis and matrix protein content that characterise the aneurysmal wall have also been found in non-aneurysmal segments of the vasculature of AAA-patients. 17, 18 Similarly, modified vessel wall properties, such as reduced distensibility, have been described not only for the aneurysm itself, but also for the (non-affected) carotid artery of patients with AAA. [19] [20] [21] In addition, some authors observed structural dilation of non-affected arteries in these patients. [20] [21] [22] [23] All together, these observations suggest that the pathogenesis of abdominal aortic aneurysms involves systemic factors that may affect the entire vascular tree of the patient. In that case alterations, similar to the changes in the aorta, could be present in other, presumed healthy, arteries of patients with AAA.
We hypothesised than an imbalance in plasma MMP/TIMP level might be associated with a systemic dilation diathesis as indicated by increased arterial diameter and stiffness. Therefore, we studied mechanical vessel wall properties of non-affected arteries of patients with either AAA or aorto-iliac occlusive disease (AOD) and measured plasma MMP-9 and TIMP-1.
Materials and Methods

Patient selection
The study group consisted of 22 consecutive patients with AAA and 12 with AOD, the latter group being chosen as a control group because of the convincing absence of a dilating diathesis in AOD patients as compared to unselected age-matched subjects. Patient characteristics of each group are listed in Table 1 . AAA patients were significantly older than AOD patients (72.3 (G5.6) vs. 65.0 (G8.2) years, PZ0.005). The other demographic details were similar for AAA and AOD patients.
Exclusion criteria were a clinical history of active infection, systemic inflammatory disease (e.g. rheumatoid arthritis, inflammatory bowel disease etc), oral or parenteral corticosteroid therapy, significant comorbidity (i.e. malignancy) and symptomatic or ruptured aneurysm. Furthermore, patients having both aneurysmal and peripheral arterial occlusive disease were excluded from the study.
Approval had been obtained from the Medical Ethical Committee of University Hospital Maastricht and all patients entered the study after giving written informed consent.
Ultrasonic assessment of aorta and carotid artery vascular wall features
The common carotid artery (CCA) and suprarenal aorta (SA) were chosen as sites of interest first because they are accessible for non-invasive ultrasound measurements and second because they are, just like the infrarenal aorta and the iliac arteries, elastic arteries (as opposed to muscular arteries such as the femoral or brachial arteries). 24 In order to assess arterial diameters and vessel wall properties non-invasively, a modified ultrasound system (Ultramark 9, ATL, Bellevue, WA, USA) attached to a custom-built wall track system 25 was used. The CCA was examined with a 7.5-MHz linear array scanner, whereas a 3.5-MHz curved array scanner was used for the abdominal aorta. All examinations were performed with the subjects in supine position after 20 min of rest. A longitudinal projection was used, the probe being placed at right angles to the arterial wall. To reduce the chance of observer bias, measurements of the CCA always were performed before the aorta was visualised. Since, diameter and vessel wall properties are usually equal on both sides, 24 only the right CCA was measured just proximal to the carotid bulb in a plaque-free area. If the presence of plaque was too extensive or a stenosis was seen on the right side, measurements were performed on the left CCA (3 AOD patients). In case of bilateral stenosis (one AAA and three AOD patients, PZ0.115, Fisher's exact test), the least affected side was used. Examination of the abdominal aorta was performed at the suprarenal level just above the origin of the most proximal renal artery. Due to the large distance between the aorta and the probe or due to bowel air blocking the transduction of ultrasound signal, the suprarenal aorta could be assessed in only 11 AAA and four AOD patients.
During ultrasound examination the arterial blood pressure was measured every 10 min with an automatic oscillometric device (Dinamap, Critikon, Tampa, Florida, USA), the cuff being placed around the upper arm. This brachial artery blood pressure was used as a substitute for the blood pressure in the CCA and aorta.
The end-diastolic diameter (d in mm) and diameter change from diastole to systole (Dd in mm) of the CCA and SA were determined as the median of five measurements during five cardiac cycles at both sites. The pulse pressure (Dp in kPa) was defined as the difference between systolic and diastolic blood pressure. Elastic properties were calculated according to the following equations. 26 Relative distension Z Dd d !100ð%Þ
Blood samples
Peripheral venous blood samples were taken from each patient directly after the ultrasound examination.
The blood was collected in EDTA tubes and centrifuged at 2423 rpm for 10 min within 1 h after collection to obtain plasma, which was stored at K20 8C until analysis.
Plasma MMP-9 and TIMP-1 measurements
Commercially available enzyme-linked immunosorbent assay (ELISA) kits (Biotrak Human ELISA System, Amersham Life Science, Buckinghamshire, UK) were used according to the manufacturer's instructions to measure plasma concentrations of MMP-9 and TIMP-1 in 19 AAA and 12 AOD patients. Blood samples of three patients in the AAA group were not suitable for analysis due to technical problems during storage. All samples were run in duplicate.
The MMP-9 assay recognises free pro-MMP-9 and the pro-MMP-9/TIMP-1 complex. Its intra-and interassay variabilities are !5.5 and !9.8%, respectively. The TIMP-1 assay recognises all forms of TIMP-1 with an intra-assay variability of !11.4% and an inter-assay variability of !15.2%. None of the assays show significant cross-reactivity with other than the target MMP or TIMP (reproducibility and cross-reactivity analyses by manufacturer).
Statistical analysis SPSS 10.0 for Windows was used for the statistics. Differences in means of continuous variables between AAA and AOD were assessed with the 1-way ANOVA or Mann-Whitney U test, as appropriate. Univariate analyses of variance were performed to correct for age differences and sex. Comparison of cardiovascular risk factors between the AAA and AOD groups was performed with Fisher's exact test. Correlations of MMP and MMP/TIMP ratio plasma levels and ultrasound parameters were tested with Spearman's correlation coefficient.
Results
Ultrasonography
Common carotid artery The CCA was measured in all 34 patients. Blood pressure, diameter, (relative) distension, distensibility and compliance are shown in Table 2 .
The CCA diameter correlated significantly with age (rZ0.38, PZ0.025). Mean CCA diameter (GSD) was 9.1 (G1.3) vs. 7.8 (G1.4) mm in the AAA and AOD group, respectively. This difference was highly significant (PZ0.009) and persisted after correction for age and sex (PZ0.022), Table 3 .
The relative distension and distensibility of the CCA decreased with age (rZK.37, PZ0.03 and rZK0.52, PZ0.002, respectively). CCA distensibility was not significantly different between AAA and AOD patients (PZ0.26). CCA compliance showed no correlation with age and did not differ between AAA and AOD patients.
Suprarenal aorta
Due to technical problems (intestinal air, depth of aorta), the SA was measured in 15 patients (11 AAA and four AOD patients) only. Data on blood pressure, diameter, (relative) distension, distensibility, compliance, age, sex, and body size are shown in Table 4 . Diameter, (relative) distension, and compliance did not correlate with age. Furthermore, none of these parameters differed between the two patient groups at the level of the suprarenal aorta. 
Plasma MMP-9 and TIMP-1 concentrations
Plasma concentrations of MMP-9 and TIMP-1 (Table 5) were similar for AAA and AOD patients. Furthermore, the MMP-9/TIMP-1 ratio, indicating the potential activity of MMP-9, did not differ between AAA and AOD patients (Table 5) .
Correlations between MMP-9 and TIMP-1 plasma levels and vessel wall characteristics
Since, no differences were found in MMP and TIMP levels between AAA and AOD patients, the patients were pooled together in order to study the relation between MMP-9/TIMP-1 and vessel wall biomechanics. No correlation was observed between MMP-9 concentration, TIMP-1 concentration or MMP-9/TIMP-1 ratio and diameter or mechanical properties of the CCA. However, as shown in Fig. 1 , the MMP-9/ TIMP-1 ratio was inversely related to the relative distension of the SA (rZK0.66, PZ0.007, nZ15), to SA distensibility (rZK0.74, PZ0.002, nZ15) and to SA compliance (rZK0.58, PZ0.024, nZ15).
Discussion
In the present study, we have shown that the common carotid artery was larger in patients with AAA compared to those with AOD. Furthermore, the MMP-9/TIMP-1 ratio was inversely related to relative distension, distensibility, and compliance of the suprarenal aorta. These data support the concept that patients with AAA suffer from a generalised condition rather than a local disease. MMP-9 activity may play a role in the systemic dilating process. Elastic arteries, such as the carotid artery 27-29 and the aorta 30,31 become stiffer with increasing age. Indeed, we found an inverse correlation between age and distensibility of the common carotid artery. Furthermore, arterial stiffness is associated with vessel diameter. As vascular elasticity decreases, the diastolic diameter increases in an attempt to keep vascular compliance, the volume buffering capacity, constant without a rise in pulse pressure. 32 This is consistent with our observation of a positive correlation between age and diameter of the CCA. Considering these agedependent changes of vascular properties, a small difference in CCA diameter between AAA and AOD patients would not be surprising, given the agedifference between these patient groups. However, the 1.3 mm increase in CCA diameter of patients with AAA compared to those with AOD remained highly significant after correction for age and sex. Furthermore, both the absolute and relative difference between the measured and the predicted CCA diameter (based on age and sex using the formula proposed by Samijo et al. 29 ) were significantly larger for AAA patients compared to AOD patients.
To reduce the chance that the presence of atherosclerotic plaques distorted our results, we performed our measurements in a plaque-free area. In cases with bilateral carotid plaques (nZ4), the less affected site was chosen for measurements. An additional analysis was done after exclusion of these cases, showing again that CCA diameter was significantly larger in patients with aneurysmal disease (data not shown). These data are in accordance with the observations of Tilson and Dang, Ward, Makita et al., and Boutouyrie et al.
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Nevertheless, Sandgren et al. found no increase in arterial dimensions in the common femoral and popliteal arteries of patients with AAA. 33 This discrepancy may result from different biomechanical and structural properties of muscular compared to elastic arteries such as the carotid artery. However, we found no difference in diameter of the suprarenal aorta in AAA vs. AOD patients. This might be attributable to the small number of observations. Dilation of a non-affected artery, such as the CCA, in patients with AAA supports the idea that AAA is a systemic disease with local manifestations in the parts of the arterial tree most sensitive to aneurysmal degeneration. This concept is further supported by observations of increased MMP activity, 17 increased collagen/elastin ratio 18 and reduced distensibility [19] [20] [21] in non-aneurysmal arterial segments of AAA patients. In contrast to the latter observation, the distensibility at the level of the common carotid artery and the suprarenal aorta was not significantly decreased in AAA compared to AOD patients in our study, although only four AOD patients were included. This is in contrast to studies comparing AAA patients and healthy control subjects used Sonesson et al. 19 and Boutouyrie et al. 20 or to the study with perfect age matching of the AAA and atherosclerotic control group by Makita et al. 21 The age difference of our patient-groups may be a critical issue. Non-invasively measured brachial blood pressure has been used as substitute for aortic and carotid arterial blood pressure, which could overestimate pressure in the aorta and carotid artery because of augmentation of pressure waves peaks by wave reflection from the periphery (arterial bifurcations). The difference between peripheral and central blood pressures decreases with age. 34 Therefore, in our population with a mean age of 70.3 years, this approximation seemed reasonable. However, since AOD patients were significantly younger than AAA patients, we might assume that the possible overestimation of central pulse pressure would be more pronounced in the AOD group, leading to a stronger underestimation of distensibility in these patients. The relatively stronger underestimation of distensibility in the AOD group may be responsible for the lack of significant difference in distensibility between AAA and AOD patients in our analysis.
MMPs have been shown to be of major importance in the pathogenesis of AAAs. [35] [36] [37] However, in contrast to others 13, 38 we did not find a difference in MMP and TIMP concentrations or MMP/TIMP ratios when comparing plasma of AAA with that of AOD patients. In agreement with our observation, a recent study reported increased MMP-9 gene expression in both atherosclerotic and aneurysmal aortic tissue. 39 Both atherosclerotic plaque and aneurysm formation are characterized by extensive remodelling. MMPs seem to play a key role in both inward and outward remodelling associated with atherosclerosis and aneurysm formation, respectively. 40 Intriguingly, the same molecular process (MMP-9 activation) leads to different outcomes in patients with aneurysmal vs. obstructive disease. The interaction of MMP-9 with genetic and environmental factors may determine the direction of the remodelling process, i.e. outward vs. inward. The familial occurrence of both aneurysmal and arterial occlusive disease indicates that a genetic basis is likely, although as yet uncharacterised. Anatomical, hemodynamical, and immunogenic variables are all dependent on a combination of hereditary and environmental (smoking, food, etc) factors. Together such factors (mediated by molecules secreted by the vessel wall or inflammatory cells) may play a key role in directing inward or outward vascular remodelling.
It is questionable whether plasma MMP-9 concentrations are directly proportional to aortic MMP-9 production and activity. To our knowledge, only Hovsepian et al. reported an exponential relationship between MMP-9 production in aneurysmal tissue and plasma MMP-9 concentration, based on measurement in four patients. 38 Nevertheless, tissue MMP-9 activity and plasma MMP-9 levels are associated with aneurysm-size, 11, 14 and even more interestingly, plasma MMP-9 levels decrease upon successful aneurysm exclusion, 15 suggesting that plasma levels of MMP-9 may reflect MMP-9 activity in diseased aortic tissue. Further studies are needed to assess the relation between plasma MMP concentration and tissue MMP production and activity.
To explore the putative role of MMP/TIMP imbalance as a systemic AAA-promoting factor, we analyzed the association between MMP/TIMP plasma levels and vessel wall characteristics, indicative of early aneurysmal changes, in healthy arterial segments of patients with AAA or AOD. Interestingly, an increased MMP-9/TIMP-1 ratio was related to a decreased suprarenal aortic distensibility and compliance. Since, the MMP-9/TIMP-1 ratio may reflect the MMP-9 activity potential, our data suggest that increased MMP-9 activity is related to increased stiffness of the suprarenal aortic wall, probably through degradation of extracellular matrix proteins such as elastin and collagen, 3, 5 the main determinants of large artery wall mechanics. We have demonstrated merely a correlation between MMP-9 activity and suprarenal aortic stiffness, and not a causal relation. Stiffening of the vascular wall may actually precede activation of MMP-9. In such a case, MMP-9 would be produced in order to stimulate outward remodelling to keep compliance at the desired level. Either way, the remodelling process will be less or more active at different sites of the arterial tree, depending on the need to compensate for increased stiffness of the vascular wall. Once compensating outward remodelling has been completed, plasma MMP-9 level may no longer be related to biomechanical vessel wall properties. This may explain why in our study the distensibility and compliance of the wide (outwardly remodelled) common carotid artery was unrelated to plasma MMP-9 concentration.
In conclusion, this study supports the idea that AAA patients exhibit a systemic dilation diathesis, indicated by an increased diameter of the common carotid artery. Given the association between a systemic biochemical marker (plasma MMP-9) and biomechanical vessel wall properties presented here, this dilation diathesis may be attributable to an MMP/TIMP imbalance.
